SCHOENECK JAMES A purchased 6613.8% of their position (75K shares) of CALIDI BIOTHERAPEUTICS, INC. on the open market
Open‑market purchase worth $150.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/25/2025ACC: 0001641172-25-025448
Director
Since Sep 2023
+150K
Net shares
Net buyer
$150.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
150K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+75K
Price / share
$2.00
Trade value
$150K
% of position
6613.8%
8/21/2025
1.13K→76.13K
Total
Net shares
+75K
Net value
$150K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/21/2025 | P · Purchase | +75K | $2.00 | $150K | 6613.8% | 1.13K | 76.13K |
| Total | +75K | $150K | ||||||
Derivative Transactions1
Warrant (right to buy)
Direct
Converts to
Common stock
75K shares
Shares
+75K
Strike price
2.00
Held after
75K
Exercisable
—
8/21/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant (right to buy) Direct | Common stock75K shares | 8/21/2025 | P · Purchase | +75K | 2.00 | — | 75K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned347.00
Common Stock
IndirectShares owned8.03K
Total
8.38K indirect8.38K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 347.00 | Indirect |
| Common Stock | 8.03K | Indirect |
| Total | 8.38K | 8.38K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported